We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!
If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.
Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.
"Tirzepatide and semaglutide share identical Black Box Warnings for medullary thyroid carcinoma; human evidence does not confirm risk, ..."
"... medullary thyroid carcinoma or MEN2 syndrome. Baseline documentation of menstrual pattern, hormonal profile, and metabolic status is recommended ..."
"The provided evidence does not specify how to adjust semaglutide dosages based on thyroid disease or family history of medullary thyroid carcinoma ..."
"Compounded semaglutide may bypass standard clinical assessment for contraindications such as personal or family history of medullary thyroid carcinoma ..."
"... thyroid follicular cell C-cell hyperplasia and medullary thyroid carcinoma risks through species-specific receptor expression patterns documented ..."
This website is intended for educational purposes only. It is not intended, nor should it be interpreted, as medical advice or instructions of any kind. Readers are advised to consult their own medical doctor(s) for all matters involving their health and medical care.